Soldiers with the U.S. Army 11th Airborne Division test a prototype Freeze-Dried Plasma kit as part of combat casualty care training during Joint Pacific Multinational Readiness Center (JPMRC), Fort Wainwright, Alaska, April 2, 2023. Blood replacement therapies are a top-tier priority for the Joint Services and U.S. Combatant Commands. FDP, managed by the Defense Health Agency’s Operational Medical Systems Program Management Office, is a shelf-stable plasma designed for use in far-forward environments, potentially saving lives during future conflicts by enabling quicker access to this vital resource while simultaneously easing the logistical burden of transporting traditional blood products. OPMED’s Warfighter Protection and Acute Care Project Management team, in partnership with stakeholders across the Department of War and development industry, have worked to increase commercial availability of FDP during the past several years to fill critical capability gaps for frontline medical providers as they prepare for future conflicts in remote, austere environments like the Indo-Pacific and Arctic regions of the globe. As part of DHA, OPMED partners with stakeholders across the Joint Force to develop, acquire, and field medical devices, treatments, and frontline care solutions for military medical providers to fill capability gaps with the speed of relevance. (U.S. Army Courtesy Photo/Released)
| Date Taken: | 04.02.2023 |
| Date Posted: | 09.08.2026 15:00 |
| Photo ID: | 9919504 |
| VIRIN: | 230402-A-A4491-2001 |
| Resolution: | 3348x2232 |
| Size: | 2.34 MB |
| Location: | FORT WAINWRIGHT, ALASKA, US |
| Web Views: | 5 |
| Downloads: | 0 |
This work, Food and Drug Administration approves lifesaving, shelf-stable plasma for far-forward battlefield care [Image 9 of 9], by T. T. Parish, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.